A central hub for advancing kidney precision medicine
Central Hub for Kidney Precision Medicine
This study is all about bringing together doctors and researchers to work closely with patients to find better ways to understand and treat kidney diseases, making sure everyone’s safety and rights are respected along the way.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11089214 on NIH RePORTER |
What this research studies
This research aims to establish a collaborative environment focused on improving kidney health through precision medicine. It will coordinate various research sites and engage with patients and the broader medical community to ensure ethical practices and participant safety. The project will facilitate the collection and sharing of high-quality data and biological samples, enhancing our understanding of kidney diseases. By fostering collaboration among researchers and clinicians, it seeks to drive significant advancements in the treatment and prevention of kidney-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals with acute or chronic kidney conditions, particularly those experiencing renal failure.
Not a fit: Patients with non-kidney-related health issues or those who do not meet the specific criteria for kidney conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for kidney diseases.
How similar studies have performed: Previous research in kidney precision medicine has shown promising results, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Himmelfarb, Jonathan — Icahn School of Medicine at Mount Sinai
- Study coordinator: Himmelfarb, Jonathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.